Correlation Between Scopus Biopharma and BiOasis Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Scopus Biopharma and BiOasis Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scopus Biopharma and BiOasis Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scopus Biopharma and biOasis Technologies, you can compare the effects of market volatilities on Scopus Biopharma and BiOasis Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scopus Biopharma with a short position of BiOasis Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scopus Biopharma and BiOasis Technologies.

Diversification Opportunities for Scopus Biopharma and BiOasis Technologies

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Scopus and BiOasis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Scopus Biopharma and biOasis Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on biOasis Technologies and Scopus Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scopus Biopharma are associated (or correlated) with BiOasis Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of biOasis Technologies has no effect on the direction of Scopus Biopharma i.e., Scopus Biopharma and BiOasis Technologies go up and down completely randomly.

Pair Corralation between Scopus Biopharma and BiOasis Technologies

If you would invest  0.20  in biOasis Technologies on September 3, 2024 and sell it today you would lose (0.19) from holding biOasis Technologies or give up 95.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.4%
ValuesDaily Returns

Scopus Biopharma  vs.  biOasis Technologies

 Performance 
       Timeline  
Scopus Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scopus Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Scopus Biopharma is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.
biOasis Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days biOasis Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, BiOasis Technologies is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Scopus Biopharma and BiOasis Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Scopus Biopharma and BiOasis Technologies

The main advantage of trading using opposite Scopus Biopharma and BiOasis Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scopus Biopharma position performs unexpectedly, BiOasis Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiOasis Technologies will offset losses from the drop in BiOasis Technologies' long position.
The idea behind Scopus Biopharma and biOasis Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Fundamental Analysis
View fundamental data based on most recent published financial statements
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas